N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1

Abstract

Background Brain metastasis (BM) is one of the principal causes of mortality for lung cancer patients. While the molecular events that govern BM of lung cancer remain frustrating cloudy. Methods The miRNA expression profiles are checked in the paired human BM and primary lung cancer tissues. The effect of miR-143-3p on BM of lung cancer cells and its related mechanisms are investigated. Results miR-143-3p is upregulated in the paired BM tissues as compared with that in primary cancer tissues. It can increase the invasion capability of in vitro blood brain barrier (BBB) model and angiogenesis of lung cancer by targeting the three binding sites of 3’UTR of vasohibin-1 (VASH1) to inhibit its expression. Mechanistically, VASH1 can increase the ubiquitylation of VEGFA to trigger the proteasome mediated degradation, further, it can endow the tubulin depolymerization through detyrosination to increase the cell motility. m 6 A methyltransferase Mettl3 can increase the splicing of precursor miR-143-3p to facilitate its biogenesis. Moreover, miR-143-3p/VASH1 axis acts as adverse prognosis factors for in vivo progression and overall survival (OS) rate of lung cancer. Conclusions Our work implicates a causal role of the miR-143-3p/VASH1 axis in BM of lung cancers and suggests their critical roles in lung cancer pathogenesis.

Full text

We don’t show the text of a retracted or withdrawn paper. The record stays, so citations to it can be checked.

Cited by papers we hold 10

• Identification of Implications of Angiogenesis and m6A Modification on Immunosuppression and Therapeutic Sensitivity in Low-Grade Glioma by Network Computational Analysis of Subtypes and Signatures · 2022
  Not checked
• m6A modification: recent advances, anticancer targeted drug discovery and beyond · 2022
  No notice
• The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers · 2022
  Not checked
• Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine · 2022
  No notice
• The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities · 2021
  No notice
• RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases · 2021
  No notice
• Novel insights into the interplay between m6A modification and noncoding RNAs in cancer · 2020
  No notice
• Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer · 2020
  No notice
• Mechanism of RNA modification N6-methyladenosine in human cancer · 2020
  No notice
• Roles of METTL3 in cancer: mechanisms and therapeutic targeting · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.